Product Information
Name:BCH001
Brand:Biosynth
Description:BCH001 is a cell-based therapy that is indicated for use in neonates with congenital heart disease. It can be used to treat pulmonary fibrosis. BCH001 is an autologous bone marrow mononuclear cell product that contains telomerase, which has the ability to stabilize and maintain telomere length. The cells are injected into the patient’s blood stream and travel through the body. BCH001 cells have been shown to be able to differentiate into various types of cells such as cardiomyocytes and endothelial cells, depending on its environment. BCH001 also has the ability to stimulate production of pluripotent stem cells by activating genes that control pluripotency markers, making it a potential treatment for congenital diseases in children.
Notice:Our products are intended for lab use only. For any other use, please contact us.
Chemical properties
Molecular weight:420.3 g/mol
Formula:C20H15F3N2O5
Purity:Min. 95%
Technical inquiry about: BCH001
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.